Abstract
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have